Expression of YES-associated protein (YAP) and its clinical significance in breast cancer tissues
- 1 October 2017
- journal article
- review article
- Published by Elsevier in Human Pathology
- Vol. 68, 166-174
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressivenessOncotarget, 2015
- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015Annals of Oncology, 2015
- Metaplastic carcinoma show different expression pattern of YAP compared to triple-negative breast cancerTumor Biology, 2014
- YAP Expression in Normal and Neoplastic Breast Tissue: An Immunohistochemical StudyArchives of Medical Research, 2014
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast CancerJournal of Clinical Oncology, 2010
- Clinicopathologic correlation of beclin-1 and bcl-2 expression in human breast cancerHuman Pathology, 2010
- Both TEAD-Binding and WW Domains Are Required for the Growth Stimulation and Oncogenic Transformation Activity of Yes-Associated ProteinCancer Research, 2009
- Transforming properties of YAP , a candidate oncogene on the chromosome 11q22 ampliconProceedings of the National Academy of Sciences, 2006
- Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic FactorsJNCI: Journal of the National Cancer Institute, 1994
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991